INTECH Investment Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

INTECH Investment Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Sell	11,664 -2,075	-15%	-$188K	0.01%	908
2026 Q1	$1.19M	Sell	13,739 -7,611	-36%	-$740K	0.01%	935
2025 Q4	$2.29M	Sell	21,350 -2,962	-12%	-$314K	0.02%	668
2025 Q3	$2.46M	Sell	24,312 -3,131	-11%	-$291K	0.02%	665
2025 Q2	$1.73M	Sell	27,443 -6,450	-19%	-$395K	0.02%	858
2025 Q1	$1.8M	Buy	33,893 +5,801	+21%	+$322K	0.02%	822
2024 Q4	$1.57M	Buy	28,092 +15,706	+127%	+$868K	0.02%	858
2024 Q3	$649K	Buy	+12,386	New	+$593K	0.01%	1079

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

INTECH Investment Management's RYTM Position: Q2 2026 in Review

INTECH Investment Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 15% in Q2 2026, selling an estimated $188K and leaving 11,664 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #908.

INTECH Investment Management first reported a position in RYTM in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.46M in Q3 2025. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

INTECH Investment Management held 11,664 shares of Rhythm Pharmaceuticals worth $1.3M as of Q2 2026.
INTECH Investment Management sold 2,075 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $188K.
Rhythm Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #908 holding.
INTECH Investment Management first reported a position in Rhythm Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Rhythm Pharmaceuticals position peaked at $2.46M in Q3 2025.
302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.